Status:
UNKNOWN
PASCAL for Tricuspid Regurgitation - a European Registry
Lead Sponsor:
LMU Klinikum
Conditions:
Tricuspid Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to investigate the safety and efficacy of the PASCAL leaflet repair system in the treatment of tricuspid regurgitation in a commercial use setting including all consecutive patients at...
Detailed Description
Tricuspid regurgitation (TR) is associated with high morbidity and mortality, but many patients are ineligible for surgical treatment due to age and co-morbidities. As a consequence, transcatheter tre...
Eligibility Criteria
Inclusion
- Patients treated with the PASCAL system for tricuspid regurgitation in a commercial setting
Exclusion
- Patient age \< 18 years
Key Trial Info
Start Date :
May 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05328284
Start Date
May 5 2021
End Date
May 30 2024
Last Update
April 14 2022
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Zentralklinik Bad Berka GmbH
Bad Berka, Germany
2
Herz & Diabeteszentrum Nordrhein Westfalen
Bad Oeynhausen, Germany
3
Universitätsklinikum Essen
Essen, Germany
4
Marienkrankenhaus Hamburg
Hamburg, Germany